Showing 1 - 1 of 1 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Dazmegrel [UK 38485] is a thromboxane synthetase inhibitor which was undergoing development in the treatment of thrombosis, ischaemic heart disease, arrhythmias and asthma. Pfizer were conducting phase II studies in Denmark and the UK, phase I studie...